Immunology and Microbiology
Poliomyelitis Virus
100%
Human Respiratory Syncytial Virus
45%
Severe Acute Respiratory Syndrome Coronavirus 2
36%
Enterovirus
28%
Immunology
28%
Influenza
27%
Human Poliovirus 2
22%
Lower Respiratory Tract
21%
Prevalence
21%
Infectious Agent
20%
Cladistics
18%
Neutralizing Antibody
18%
Human Immunodeficiency Virus
18%
Lineages
16%
Serotype
12%
Next Generation Sequencing
12%
Dynamics
12%
Oral Poliomyelitis Vaccine
11%
Viral Load
10%
Human Poliovirus 1
10%
Evolution
10%
Wild Type
10%
Virus Evolution
10%
Molecular Epidemiology
10%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Disease Burden
9%
Human Immunodeficiency Virus 1
9%
Yellow Fever
9%
Schistosomiasis
9%
Yellow Fever Vaccine
9%
Antibody Response
9%
Echovirus 9
9%
Helminthiasis
9%
Genomic Surveillance
9%
Bird
9%
Population Dynamics
9%
Hepatitis B Virus
9%
Hepatitis Delta Virus
9%
Hepatitis B
9%
Enterovirus B
8%
Phylogeny
5%
Seroconversion
5%
Antibody Titer
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
47%
Flaccid Paralysis
35%
Human Poliovirus 2
30%
Respiratory Tract Infection
28%
Poliomyelitis Virus
27%
Infection
27%
Human Respiratory Syncytial Virus
27%
Poliomyelitis
27%
Medical Research
22%
Yellow Fever
20%
Pathogen
15%
Disease
14%
Molecular Diagnosis
13%
Oral Poliomyelitis Vaccine
11%
COVID-19
11%
Surveillance System
10%
Next Generation Sequencing
10%
Influenza
10%
Toddlers
9%
Cross Sectional Study
9%
Diagnosis
9%
Lower Respiratory Tract Infection
9%
Coronavirinae
9%
Enterovirus D68
9%
Drug Resistance
9%
Bacterial Infection
9%
Avian Influenza
9%
Disease Burden
9%
Resistance Mutation
9%
Radiation Therapy
9%
Yellow Fever Virus
9%
Malignant Neoplasm
9%
Yellow Fever Vaccine
9%
Antibody Response
9%
Human Immunodeficiency Virus
9%
Evolution
9%
Adverse Event
7%
Coughing
7%
Paralysis
7%
Phylogeny
6%
Health Service
5%
Seroconversion
5%
Case Fatality Rate
5%
Pharmacology, Toxicology and Pharmaceutical Science
Human Respiratory Syncytial Virus
45%
Poliomyelitis Virus
36%
Flaccid Paralysis
34%
Poliomyelitis
33%
Human Poliovirus 2
30%
Lower Respiratory Tract Infection
21%
SARS Coronavirus
18%
Respiratory Tract Infection
18%
Disease
14%
Oral Poliomyelitis Vaccine
11%
HIV
10%
Procyanidin
9%
Cacao
9%
Enterovirus D68
9%
Human Immunodeficiency Virus 1
9%
Drug Resistance
9%
Repurposing
9%
Yellow Fever Vaccine
9%
Enterovirus
9%
Yellow Fever
9%
Schistosomiasis
9%
Helminthiasis
9%
Adverse Event
7%
Paralysis
7%
Case Fatality Rate
5%
Infection
5%